References
- Bardo M. T., Bhatnagar R. K., Gebhart G. F. Age‐related differences in the effect of chronic administration of naloxone on opiate binding in rat brain. Neuropharmacology 1984; 22: 453–461
- Bugnon C., Bloch B., Lenys D., Fellman D. Étude cytoimmunologique chez le foetus humain et chez l'homme adulte de nerones hypothalamiques susceptibles d'elahorer divers peptides de type andorphines. ACTH, LPH, et MSH a partir d'un precursor commun. Journal of Physiology (Paris) 1979; 75: 67–87
- Butler I. J., Koslow S., Seifert W. Biogenic amine metabolism in Tourette syndrome. Annuls of Neurology 1979; 6: 37–39
- Gillman M. A., Sandyk R. Gilles de la Tourette syndrome‐effect of analgesic concentrations of nitrous oxide. British Medical Journal 1984; 288: 114
- Gillman M. A., Sandyk R. The opioid system in Tourette syndrome. Psychiatry, Research 1985; 15: 161–162
- Haynes L. W. Opioid systems and the developing brain. Trends in Pharmacological Sciences 1984; 5
- Leckman J. F., Cohen D. J., Detlor J. Clonidine in the treatment of Tourette syndrome: a review of data. Advances in Neurology 1982; 35: 391–401
- Sandyk R. The opioid‐noradrenergic link in Tourette's syndrome. Clinical Pharmacy 1985; 4: 502
- Sandyk R. The effects of naloxone in Tourette syndrome. Annals of Neurology 1985; 18: 367–368
- Sandyk R. Tourette syndrome: successful treatment with clonidine and oxycodone. Journal of Neurology 1986; 233: 178–179
- Sandyk R. Naloxone ameliorates autoaggressive behaviour in Tourette's syndrome. Neurology
- Shapiro A. K., Shapiro E., Wayne H. L. The symptomatology and diagnosis of Gilles de le Tourette syndrome. Journal of the American Academy of Child Psychiatry 1973; 12: 702–723
- Sweet R. D., Solomon G. E., Wayne H. Neurological features of Gilles de la Tourette syndrome. Journal of Neurology, Neurosurgery and Psychiatry 1973; 36: 1–9